Allo-HSCT(First Affiliated Hospital Of Zhejiang University)

N/A

Report date: 2025/03/07 20:00:40

Base Information

Drug NameAllo-HSCT(First Affiliated Hospital Of Zhejiang University)
Drug Alias NameAllogeneic Hematopoietic Stem Cell Transplantation(First Affiliated Hospital Of Zhejiang University)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapyCell and gene therapy > Cell therapy > Donor > Allogeneic
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesFirst Affiliated Hospital Of Zhejiang University
China Registration ClassN/A

Develop Information

Active CompaniesFirst Affiliated Hospital Of Zhejiang University
Inactive CompaniesN/A
Active IndicationsPrecursor Cell Lymphoblastic Leukemia-Lymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A